Caricamento...
Complete response of mediastinal clear cell sarcoma to pembrolizumab with radiotherapy
BACKGROUND: Clear cell sarcoma (CCS) is a rare, aggressive soft tissue sarcoma thought to derive from neural crest and characterized by a 12;22 translocation. The resulting fusion protein directly activates expression of the melanocyte master transcription factor and drives the same down-stream path...
Salvato in:
| Pubblicato in: | Clin Sarcoma Res |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5513342/ https://ncbi.nlm.nih.gov/pubmed/28725344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13569-017-0079-1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|